Lentitek
Lentitek specialises in developing manufacturing technologies for lentiviral vectors, which are essential in the delivery of CAR-T cell and gene therapies – breakthrough treatments for cancer and genetic disorders.
Edinburgh, UKwww.lentitek.com ↗
Total raised
€830k
€830,011
Funding rounds
1
Investors
1
distinct backers
Active since
2025-03
latest 2025-03
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood33
base rate 30% for Other
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-03-11 | Other | €830k | Equity Gap | View deal → |